Achieving the highest standard of ethical corporate conduct

Philips North America LLC, a division of Royal Philips., and its affiliates (“Philips” ), has established and is operating under a Comprehensive Compliance Program (“CCP”).

Where applicable, is in accordance with the “Compliance Program Guidance for Pharmaceutical Manufacturers” issued by the United States Department of Health and Human Services Office of Inspector General (“CPG”), and the AdvaMed and NEMA/MITA Codes of Ethics on Interactions with Healthcare Providers (“Device Industry Codes”).

Not a drug manufacturer
Because Philips is a medical device manufacturer – not a drug manufacturer – certain guidance set forth in the CPG does not apply to Philips and its operations. Similarly, Philips’ CCP is based on Device Industry Codes and not the PhRMA Code of Ethics for the pharmaceutical industry.

With these clarifications and Philips’ good faith understanding of the statutory requirements, Philips is – to the best of its knowledge – in compliance with the provisions of the California Health and Safety Code §§119400-119402, to the extent they apply to Philips North America LLC.
[Updated 01-01-2022] 

Compliance updates
Please note that our Philips compliance program may vary from country to country to reflect legal differences, and not all programs are available for posting.